Protokoly_diagnostiki_i_lechenia_zabolevany
.pdf' , " !@ 2 " # , , (
% ) |
& $ , |
( ") – |
& $. |
" ,
+ "
%
@ , 4,0
D # , 4,0
D #
D # %
?@ Š 140/90 . . .
+ "
" % (% % , " " , ,$# - & ) & &
" .
+ :" .
% :
1.B % :
-& %
-: & % , , "$, ; " & # , , % "$
-& – & K ( 3 ) " & $, " ,$ #&$ &, ( 1 )
" & :
1.B , & , B6;
2.B ; <, ;/ <
3.B &
6 |
_? % : |
|
||
- |
& , % |
|||
|
& &$ " ; |
|
||
- |
& & |
!@; |
||
- |
& |
$ |
% $& |
!@, & |
|
( & , & , |
|||
|
" ); |
|
|
|
- |
" & % & |
!@; |
||
-& " !@, & &$ ;
-& " " & !@, & &$ " ;
-& , 3 , & , , & " ;
-# & & !@, &% , # & " "$ &;
-& !@ ( . . " ,, % # , ,% # ) " $ #" 2 " ;
" & &
– $ . 2,8 &/% – 40 40% $ " ,. , " &% & " – %& " 0,1 / /" " # & .
, !@ (B<!, & , , & . .), – #& $# .
" & :
2.6
3.!
4.? ?@
5.6 " _?% .
,- ! :
% & &$ " :
1.!@ " "
2." & !@
9 :
1. "$ , # % , " . <. . < , 6. >. ) & , ;. _. , K.
!. ? . ? , 2005
2." " / . L. Dobrossy. - , 2003. 168 .
" :
1. B6; – . ' " : / ( )². '
% # - 25 / ², %" – 27 / ²
2.; – % &
3.< – % &
* – , # (% % )
|
5, |
: 02-021 |
|
"$ &: " |
|
: 6! ( |
) |
& ! : |
, 3 , % |
|
|
(: H10 V$ |
|
) : V$ – & V$ " ,$# " , ;
% |
% . V$ $ 30 % |
|
. |
$ : "$ – , " . |
|
* : . |
|
|
: ) , % % |
V # # : & , ( " " ), & - V$& , &. L # %$ ( " , ). V : , , # , V$. + % & V$ " , " % & %.
" & :
1.? "
2.V
4.+ %
" & & :
+ :
-" # & ( % &).
-@ " V$& $
: 1:5000 .
- @ " V$ " " &3-7 . ' V$& $ J! "& % 2-4 " , & "& 3-6 . " 7-10 . ? &: 0,25% - ,
0,02% , & 30% , & 0,5%. " V$ - , ,0,3% - . – (-& ).
" & :
1.+ 20 .
2.* 1:10 000
3.*G 0,25%
4.*+ 0,02%
5.*! & 30%
6.*+ & 0,5%
7.*@ V 1% 1
" & & :
,- ! : 3 & " 3 .
/ , & :
1.American Academy of Ophthalmology. Guideline. Conjunctivitis. 2003 2.Prodigy Knowledge. Prodigy Guidance. Conjunctivitisinfective. 2004 3. Prodigy Knowledge. Prodigy Guidance. Conjunctivitisallergic. 2004
4.International Council of Ophthalmology. Guideline. Conjunctivitis (Initial evaluation) 2005 5.EBM Guidelines. Conjunctivitis. 2004
6.Sheikh A., Hurvitz B, Cave J. Antibiotics versus placebo for acute bacterial conjunctivitis. In: Cochrane Library.
7.@ & . >% " . 2003 - L & 7. - !. 2314-2321.
* – , # (% % ) .
)8
: 22-178
"$ &: " : 6! ( )
& ! : & %$ $ #&, 3$ .
(: ;30 ; " " % " " ) : )8 $ % , " , "
" 3 . ; % & % " # % |
|
. L & |
# & % % , % " % . |
$ : ' |
% $ " % : |
I |
& - % % ; |
|
II |
& – |
, % &$; |
III ? & – 3 |
( " % ); |
|
III < & – % $ # ; |
||
IV & – % % # . |
||
6<-10 3- $ $ % % . * : % # , 3 " , "
% , & |
" " ( ) |
|
$# " . |
|
|
|
: I – II |
& – " & & % , |
% & ( %
# – , |
& % |
% ). II |
||
$ " 2 " |
" % , |
" , , |
||
3 . III |
– " & & % |
|||
$, % , |
% |
, |
|
% , |
" . 7 " % . " & &,
, " |
& . |
|
|
|
" |
|
# |
% % $ # |
|
. |
" & % , # % II |
III |
||
, |
$# 25% , |
|||
10% $ $ & # , % &. "$ $# ( ) % : % A ,, .
" & : " & & :
+ |
: |
||
- & , % ; |
|||
- |
# % " " " " |
||
% ; |
|
|
|
- |
" % – & %%$ & (t 20-25 °C) |
||
" 10 .; |
|||
- |
" % – & $ & |
||
|
" " 30 .( % &$ " |
||
|
|
!). |
|
% :
- 100-200 ( " ) & 50% 2-4 " . + " $; - % % 3 ;
- " ( & ) & ;% & ,& - , .
% & : $ 5% , $& &$ 2 " 0,5 " . @ 1% 1 , 60-90 , 100-200 . ' ;.
" & :
1. *6 V 100 /1 ,
2. * , " , #$# ( $)
3.*; 50 ; 50 /1
4.*@ V 1% 1
5.* V 30 / ; 5
" & & :
,- ! :
) % ; ) % ;
) " % ;
) |
% II 10% ( % II |
|
|
5% |
). III 3% ( % III ). |
III $ |
# % , , , % , 3 % . |
|
$ , % % . " % - " . 3" & % & . & " !'?.
* – , # (% % ) .
) 8
: 06-062o
"$ &: " : 6! ( )
& ! : @ # 3 " .
(: 25 %
26 |
|
|
|
35 |
|
|
|
40 % |
|
|
|
56 |
" |
|
|
65 |
|
|
|
81 |
|
|
|
85 |
|
|
|
) : ) 8 – " , $# |
|
||
% " $ |
. |
||
% " & . 7 " # |
&$ |
|
|
" , & " " ,
3 & . |
|
|
|
|
|
|||||||
"$ % & |
% $ |
|||||||||||
$ |
, |
& , |
, |
|||||||||
, , |
, % |
|
||||||||||
$ |
, |
" |
$ $ &, $ |
|||||||||
, & " , |
( % |
|||||||||||
, |
|
" , |
& |
|
|
|
) |
|
|
|||
. |
|
|
|
|
|
|
|
|
|
|
|
|
* : + " " " $ |
|
|||||||||||
, |
. |
|
|
|
|
|
|
|
|
|||
|
|
: |
|
|
|
|
|
|
|
|
|
|
-& |
|
& |
$ ; |
|
|
|
|
|
||||
- « » % |
$ ; |
|
|
|
|
|||||||
- % $, & $ ;
-, % ;
-, .
% Q Q :
- % , & & " ;
-, % ?@;
-% & ;
- " , $& , & % ; - , .
L , & " % .
) % # % " " " &$ " .
' , " 3 " ,$# $ , % && ,% .
" & : " & & :
+ :
-#$ & ( #&$" ), # & $& ;
-& : $ , " % $, & , & , ?@, % , . " , " ,$ , % , % ?@ (" ) " :$ ( $ $ 5% ) , ,60-120 & . + & & . % "-" " " &: 3 12,5% - 2-4 / / .% "-" " ( % ?@, )- $ ( $) & " ?@ 90 - 100 . . / , Q 0,5% 5.
-3 " , % . % "-
" " & $ # ; - % ( " # )$ % % .
" & :
1.*$ ( $) 200 , 500 ,
2.* V 30 / ; 5
3.7 V 125 , 250 /2 ,
4. *@ V 0,5%, 4% 5
" & & :
,- ! : + " " % . * – , # (% % ) .
: 23-316
"$ &: " : 6! ( )
& ! : $# 3(: !34 "
) :
( ; & ) " , # 3 % " .
$ :
- "
" ( 40-45% " ) # %$
, & (25-30% " ),
# $
" ( 10% " ) - " ( 20-25% " )
#- :
/ & " .
/ & % ( $" & ). " . / &
|
3 , $. |
" " . |
|
|
? " : " ( & ), & |
" .
6 & "" " . J & " .
" – "-% . J " & & " . B & " " " .
* :
3. |
" ( & , ) |
4." ( )
|
|
|
: |
|
|
|
|
% & $, |
|
$ |
|||||
$# 3 & - V " : |
|
||||||
& |
|
|
|
|
|
|
|
< & |
|
|
|
||||
|
|
|
|
|
|
|
|
! % |
|
|
|
|
|
||
& |
|
( & |
&$ |
|
|||
) |
|
|
|
|
|||
H # |
|
|
|
||||
! |
( |
% /+!, " |
|||||
|
" & , ) |
|
|
|
|||
H " ( , $" " , " ) |
|
|
|||||
+ |
|
&-: % |
& |
" |
|||
&$ |
" $# : |
|
|
|
|||
&
@ " $ "
($" & )
! ( " ,,&$ )
! ( " )
& & |
|
|
" " |
|||
" ( |
, & % & ) |
|||||
6 & % & " |
|
|
&$ |
|||
&-. |
|
|
|
|
|
|
" % " & |
|
|||||
. |
&$ |
|
|
|
$ |
|
|
& |
|||||
|
|
|
|
|
|
|
" & – % " . < & & " &( % ). ' 3
& & & , & " . |
||
' " " % : |
||
) & |
& |
|
|
% " ; |
|
) 3 " |
& |
$# % " , |
# , |
# . |
|
" & : |
||
" & & : |
||
+ :
" & : " "
|
|
. |
" & & : |
||
|
,- !: |
$ |
" « ». |
|
|
/ , & :
1.Diagnosis of lung cancer: the guidelines/ Chest 2003;
2.Management of patients with lung cancer. A National clinical guideline. Scottish Intercollegiate Guidelines Network (SIGN).2005;
3.Treatment of early stage non-small cell lung cancer. Chest 2003;
4.The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 2003;
5." $ " " . B.+.@ , M.J.K " . 6. 2004;
6.@ & . >% " . ' 2-2003;
7." " / . L. Dobrossy. – <.: 2003.
* – , # (% % ) .